In conclusion, our findings suggest that although an RCD significantly reduces the total daily dose of insulin in individuals with type 1 diabetes, it does not lead to measurable improvements in insulin sensitivity or endothelial function compared to an SCD. Here, INS is linked to type 1 diabetes mellitus.